The past and future of breast cancer treatment—from the papyrus to individualised treatment approaches

por Ades, Felipe, Tryfonidis, Konstantinos, Zardavas, Dimitrios
Publicado 2017

Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

por Takahashi, Masato, Cortés, Javier, Dent, Rebecca, Pusztai, Lajos, McArthur, Heather, Kümmel, Sherko, Denkert, Carsten, Park, Yeon Hee, Im, Seock-Ah, Ahn, Jin-Hee, Mukai, Hirofumi, Huang, Chiun-Sheng, Chen, Shin-Cheh, Kim, Min Hwan, Jia, Liyi, Li, Xin Tong, Tryfonidis, Konstantinos, Karantza, Vassiliki, Iwata, Hiroji, Schmid, Peter
Publicado 2023

Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5–13/TESARO PR-30–50–10-C BRAVO Study

por Turner, Nicholas C., Balmaña, Judith, Poncet, Coralie, Goulioti, Theodora, Tryfonidis, Konstantinos, Honkoop, Aafke H., Zoppoli, Gabriele, Razis, Evangelia, Johannsson, Oskar T., Colleoni, Marco, Tutt, Andrew N., Audeh, William, Ignatiadis, Michail, Mailliez, Audrey, Trédan, Olivier, Musolino, Antonino, Vuylsteke, Peter, Juan-Fita, Maria Jose, Macpherson, Iain R.J., Kaufman, Bella, Manso, Luis, Goldstein, Lori J., Ellard, Susan L., Láng, István, Jen, Kai Yu, Adam, Virginie, Litière, Saskia, Erban, John, Cameron, David A.
Publicado 2021